• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I期肺癌被动散射质子束治疗后的晚期放射学改变。

Late radiological changes after passive scattering proton beam therapy for Stage I lung cancer.

作者信息

Nakamura Naoki, Hojo Hidehiro, Inoue Kazuya, Hotta Kenji, Zenda Sadamoto, Baba Hiromi, Onozawa Masakatsu, Motegi Atsushi, Nakamura Masaki, Kibe Yuichi, Akimoto Tetsuo

机构信息

Division of Radiation Oncology and Particle Therapy, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan.

Department of Radiology, Takai Hospital, 470-8 Kuranosho, Tenri, Nara, Japan.

出版信息

J Radiat Res. 2018 Jul 1;59(4):456-461. doi: 10.1093/jrr/rry028.

DOI:10.1093/jrr/rry028
PMID:29790995
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6054174/
Abstract

This study aimed to examine late radiological changes after proton beam therapy (PBT) for early-stage non-small cell lung cancer (NSCLC) and to clarify correlations between mass-like radiological changes and patient characteristics. CT scans of patients who underwent passive scattering PBT for T1-2N0M0 NSCLC were analyzed retrospectively. Patients were considered eligible if follow-up CT was performed for at least 2 years, with no definite evidence of local recurrence. The following five periods were defined: (i) 6-12 months, (ii) 12-24 months, (iii) 24-36 months, (iv) 36-48 months and (v) 48-60 months after PBT. Late (≥6 months) radiological changes were scored by consensus of three radiation oncologists according to classifications set forth by Koenig (Radiation injury of the lung after three-dimensional conformal radiation therapy. AJR Am J Roentgenol 2002;178:1383-8.). CT scans of 113 patients (median follow-up, 36 months; range, 24-137 months) were evaluated. Late radiological changes during Periods (i), (ii), (iii), (iv) and (v) included modified conventional pattern (80%, 79%, 72%, 58% and 56%, respectively), mass-like changes (8%, 9%, 14%, 22% and 18%, respectively), scar-like changes (4%, 9%, 11%, 17% and 24%, respectively) and no increased density (8%, 3%, 3%, 2% and 2%, respectively). Mass-like changes were observed in 23 patients (20%). Among patients who developed mass-like changes, the median interval between the initiation of PBT and the onset of mass-like changes was 19 months (range, 6-62 months). In multivariate analysis, a peripheral location was found to be a significant factor (P = 0.035; odds ratio: 4.44; 95% confidence interval: 1.12-21.28). In conclusion, mass-like changes were observed in 20% of patients who underwent PBT. Patients with peripheral tumors showed a higher incidence of mass-like changes.

摘要

本研究旨在探讨早期非小细胞肺癌(NSCLC)质子束治疗(PBT)后的晚期影像学变化,并阐明类似肿块的影像学变化与患者特征之间的相关性。对接受被动散射PBT治疗T1-2N0M0 NSCLC的患者的CT扫描进行回顾性分析。如果随访CT至少进行2年且无明确的局部复发证据,则认为患者符合条件。定义了以下五个时期:(i)PBT后6-12个月,(ii)12-24个月,(iii)24-36个月,(iv)36-48个月和(v)48-60个月。由三位放射肿瘤学家根据Koenig提出的分类标准(三维适形放射治疗后肺的放射损伤。AJR美国放射学杂志2002;178:1383-8)达成共识,对晚期(≥6个月)影像学变化进行评分。对113例患者(中位随访时间36个月;范围24-137个月)的CT扫描进行了评估。在时期(i)、(ii)、(iii)、(iv)和(v)的晚期影像学变化包括改良传统模式(分别为80%、79%、72%、58%和56%)、类似肿块的变化(分别为8%、9%、14%、22%和18%)、类似瘢痕的变化(分别为4%、9%、11%、17%和24%)以及密度无增加(分别为8%、3%、3%、2%和2%)。23例患者(20%)出现类似肿块的变化。在出现类似肿块变化的患者中,PBT开始至类似肿块变化出现的中位间隔时间为19个月(范围6-62个月)。多因素分析显示,周围型是一个显著因素(P = 0.035;优势比:4.44;95%置信区间:1.12-21.28)。总之,接受PBT的患者中有20%出现类似肿块的变化。周围型肿瘤患者出现类似肿块变化的发生率更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c5d/6054174/f9368612b4fb/rry028f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c5d/6054174/bf7c637de809/rry028f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c5d/6054174/f0cf48f2bfbd/rry028f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c5d/6054174/f9368612b4fb/rry028f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c5d/6054174/bf7c637de809/rry028f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c5d/6054174/f0cf48f2bfbd/rry028f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c5d/6054174/f9368612b4fb/rry028f03.jpg

相似文献

1
Late radiological changes after passive scattering proton beam therapy for Stage I lung cancer.I期肺癌被动散射质子束治疗后的晚期放射学改变。
J Radiat Res. 2018 Jul 1;59(4):456-461. doi: 10.1093/jrr/rry028.
2
First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.质子束疗法用于非小细胞肺癌术后放疗的首例临床报告
Clin Lung Cancer. 2017 Jul;18(4):364-371. doi: 10.1016/j.cllc.2016.12.009. Epub 2017 Jan 5.
3
No differences in radiological changes after 3D conformal vs VMAT-based stereotactic radiotherapy for early stage non-small cell lung cancer.对于早期非小细胞肺癌,三维适形放疗与容积调强弧形放疗相比,放射学改变无差异。
Br J Radiol. 2017 Oct;90(1078):20170143. doi: 10.1259/bjr.20170143. Epub 2017 Sep 4.
4
Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas : Ablative dose PBT for NSCLC.I期和复发性非小细胞肺癌的消融剂量质子束治疗:非小细胞肺癌的消融剂量质子束治疗
Strahlenther Onkol. 2016 Sep;192(9):649-57. doi: 10.1007/s00066-016-0985-9. Epub 2016 Jun 9.
5
Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer.外周I期非小细胞肺癌大剂量质子束治疗的临床结果及预后因素
Clin Lung Cancer. 2016 Sep;17(5):427-432. doi: 10.1016/j.cllc.2015.11.013. Epub 2015 Nov 30.
6
The clinical results of proton beam therapy in patients with idiopathic pulmonary fibrosis: a single center experience.特发性肺纤维化患者质子束治疗的临床结果:单中心经验
Radiat Oncol. 2016 Apr 18;11:56. doi: 10.1186/s13014-016-0637-3.
7
Outcomes and prognostic factors for recurrence after high-dose proton beam therapy for centrally and peripherally located stage I non--small-cell lung cancer.中心型和周围型I期非小细胞肺癌大剂量质子束治疗后复发的结局及预后因素
Clin Lung Cancer. 2014 Mar;15(2):e7-12. doi: 10.1016/j.cllc.2013.11.002. Epub 2013 Nov 13.
8
Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.局限期小细胞肺癌质子束放射治疗的前瞻性研究。
Cancer. 2017 Nov 1;123(21):4244-4251. doi: 10.1002/cncr.30870. Epub 2017 Jul 5.
9
High-dose proton beam therapy for stage I non-small cell lung cancer: Clinical outcomes and prognostic factors.高剂量质子束治疗I期非小细胞肺癌:临床结果与预后因素
Acta Oncol. 2015 Mar;54(3):307-14. doi: 10.3109/0284186X.2014.948060. Epub 2014 Oct 7.
10
Dosemetric Parameters Predictive of Rib Fractures after Proton Beam Therapy for Early-Stage Lung Cancer.预测早期肺癌质子束治疗后肋骨骨折的剂量学参数
Tohoku J Exp Med. 2016 Apr;238(4):339-45. doi: 10.1620/tjem.238.339.

引用本文的文献

1
Spectrum of Imaging Patterns of Lung Cancer following Radiation Therapy.放射治疗后肺癌的影像模式谱
Diagnostics (Basel). 2023 Oct 23;13(20):3283. doi: 10.3390/diagnostics13203283.

本文引用的文献

1
Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned.立体定向消融放疗治疗中央型早期非小细胞肺癌:我们的经验教训。
J Thorac Oncol. 2015 Apr;10(4):577-85. doi: 10.1097/JTO.0000000000000453.
2
Late radiologic changes after stereotactic ablative radiotherapy for early stage lung cancer: a comparison of fixed-beam versus arc delivery techniques.立体定向消融放疗治疗早期肺癌后的晚期放射学改变:固定束与弧形传输技术的比较。
Radiother Oncol. 2013 Oct;109(1):77-81. doi: 10.1016/j.radonc.2013.08.034. Epub 2013 Sep 20.
3
Surgery versus stereotactic radiotherapy for patients with early-stage non-small cell lung cancer: more data from observational studies and growing clinical equipoise.
Cancer. 2013 Aug 1;119(15):2668-70. doi: 10.1002/cncr.28101. Epub 2013 Apr 19.
4
Computed tomography-based anatomic assessment overestimates local tumor recurrence in patients with mass-like consolidation after stereotactic body radiotherapy for early-stage non-small cell lung cancer.基于计算机断层扫描的解剖评估在立体定向体部放射治疗早期非小细胞肺癌后出现块状实变的患者中高估了局部肿瘤复发。
Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1071-7. doi: 10.1016/j.ijrobp.2012.01.088. Epub 2012 Aug 14.
5
Radiographic changes after lung stereotactic ablative radiotherapy (SABR)--can we distinguish recurrence from fibrosis? A systematic review of the literature.肺部立体定向消融放疗(SABR)后的放射学改变——我们能否区分复发与纤维化?系统文献回顾。
Radiother Oncol. 2012 Mar;102(3):335-42. doi: 10.1016/j.radonc.2011.12.018. Epub 2012 Feb 1.
6
Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.立体定向消融放疗治疗有手术机会的 I 期非小细胞肺癌患者的结果。
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):348-53. doi: 10.1016/j.ijrobp.2011.06.2003. Epub 2011 Nov 19.
7
Radiological changes after stereotactic radiotherapy for stage I lung cancer.立体定向放疗后Ⅰ期肺癌的放射学变化。
J Thorac Oncol. 2011 Jul;6(7):1221-8. doi: 10.1097/JTO.0b013e318219aac5.
8
Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?立体定向体部放疗(SBRT)治疗可手术的 I 期非小细胞肺癌:SBRT 能否与手术相媲美?
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1352-8. doi: 10.1016/j.ijrobp.2009.07.1751. Epub 2010 Jul 16.
9
Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT).立体定向体部放射治疗(SBRT)后早期和晚期肺部放射性损伤。
Lung Cancer. 2010 Jul;69(1):77-85. doi: 10.1016/j.lungcan.2009.09.006. Epub 2009 Nov 11.
10
A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy.一项对接受低分割立体定向体部放射治疗的无法手术的 I 期非小细胞肺癌患者进行的 18F-氟脱氧葡萄糖正电子发射断层扫描序贯试验。
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):789-95. doi: 10.1016/j.ijrobp.2009.02.051. Epub 2009 May 25.